Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency
Nutrients, 2026;18(13)
GLP-1 and Alcohol-Related Behaviors: Insights From Preclinical Studies
Biological psychiatry, 2026
Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs: A Systematic Review and Pairwise Meta-Analysis
Cureus, 2026;18(6):e111363
Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices
The Analyst, 2026
Obesity Management Pharmacotherapies and Lifestyle Treatment for Pediatric Obesity Management: A Systematic Review and Network Meta-Analysis
JAMA pediatrics, 2026
Residual gastric content after tirzepatide discontinuation: is one week enough?
Minerva anestesiologica, 2026
LY6D promotes hepatic steatosis via the GRB2-AMPK-SREBP1 signaling axis
International journal of obesity (2005), 2026
Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity
Diabetes, obesity & metabolism, 2026
GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: Insights from a Pilot Implementation Program
Canadian journal of diabetes, 2026
Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node Cells
Circulation, 2026;153(25):2110-2113
Clinical Impact of Semaglutide in Patients with Heart Failure and Preserved Ejection Fraction
Journal of clinical medicine, 2026;15(12)
Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review
International journal of molecular sciences, 2026;27(12)
Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases
Drug metabolism and disposition: the biological fate of chemicals, 2026;54(8):100346
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome
Frontiers in immunology, 2026;17:1849387
Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence
Cureus, 2026;18(6):e111322
Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024
Acta psychiatrica Scandinavica, 2026
Short- and Long-term Effects of Semaglutide 2.4 mg on Energy Intake, Appetite, and Food Reward: A 60-week, Double-Blind Randomized Controlled Trial
The American journal of clinical nutrition, 2026;:101403
Long-term effects of weight-reducing drugs in people with hypertension
The Cochrane database of systematic reviews, 2026;6:CD007654
Pulmonary adverse events associated with GLP-1 receptor agonists: a systematic review of respiratory safety signals
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs)
International journal of obesity (2005), 2026